Live feed08:00:00·8dPRReleasevia QuantisnowKyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AMLByQuantisnow·Wall Street's wire, on your screen.KURA· Kura Oncology Inc.Health Care
